Raymond James & Associates’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.14M | Sell |
58,892
-3,992
| -6% | -$281K | ﹤0.01% | 1775 |
|
|
2024
Q2 | $5.18M | Sell |
62,884
-7,309
| -10% | -$602K | ﹤0.01% | 1548 |
|
|
2024
Q1 | $6.13M | Buy |
70,193
+14,982
| +27% | +$1.31M | ﹤0.01% | 1442 |
|
|
2023
Q4 | $5.32M | Buy |
55,211
+201
| +0.4% | +$19.4K | ﹤0.01% | 1490 |
|
|
2023
Q3 | $4.87M | Sell |
55,010
-357
| -0.6% | -$31.6K | ﹤0.01% | 1466 |
|
|
2023
Q2 | $4.8M | Buy |
55,367
+5,126
| +10% | +$444K | ﹤0.01% | 1502 |
|
|
2023
Q1 | $4.89M | Sell |
50,241
-10,168
| -17% | -$989K | ﹤0.01% | 1473 |
|
|
2022
Q4 | $6.25M | Buy |
60,409
+2,517
| +4% | +$260K | 0.01% | 1268 |
|
|
2022
Q3 | $4.91M | Sell |
57,892
-8,242
| -12% | -$699K | 0.01% | 1390 |
|
|
2022
Q2 | $5.48M | Buy |
66,134
+19,378
| +41% | +$1.61M | 0.01% | 1341 |
|
|
2022
Q1 | $3.61M | Sell |
46,756
-104,537
| -69% | -$8.06M | ﹤0.01% | 1737 |
|
|
2021
Q4 | $13.4M | Sell |
151,293
-515
| -0.3% | -$45.5K | 0.01% | 946 |
|
|
2021
Q3 | $11.7M | Buy |
151,808
+16,857
| +12% | +$1.3M | 0.01% | 969 |
|
|
2021
Q2 | $11.3M | Buy |
134,951
+6,059
| +5% | +$506K | 0.01% | 1010 |
|
|
2021
Q1 | $9.73M | Sell |
128,892
-74,211
| -37% | -$5.6M | 0.01% | 1050 |
|
|
2020
Q4 | $17.8M | Buy |
203,103
+32,613
| +19% | +$2.86M | 0.02% | 670 |
|
|
2020
Q3 | $13M | Sell |
170,490
-26,046
| -13% | -$1.98M | 0.02% | 730 |
|
|
2020
Q2 | $24.2M | Sell |
196,536
-2,716
| -1% | -$335K | 0.03% | 455 |
|
|
2020
Q1 | $16.8M | Buy |
199,252
+35,194
| +21% | +$2.97M | 0.03% | 516 |
|
|
2019
Q4 | $13.9M | Sell |
164,058
-21,179
| -11% | -$1.79M | 0.02% | 748 |
|
|
2019
Q3 | $12.5M | Sell |
185,237
-9,554
| -5% | -$644K | 0.02% | 751 |
|
|
2019
Q2 | $16.7M | Buy |
194,791
+9,455
| +5% | +$810K | 0.02% | 610 |
|
|
2019
Q1 | $16.5M | Buy |
185,336
+10,968
| +6% | +$974K | 0.03% | 590 |
|
|
2018
Q4 | $14.8M | Buy |
174,368
+120
| +0.1% | +$10.2K | 0.03% | 581 |
|
|
2018
Q3 | $16.9M | Buy |
174,248
+6,279
| +4% | +$609K | 0.03% | 595 |
|
|
2018
Q2 | $15.8M | Buy |
167,969
+61,434
| +58% | +$5.79M | 0.03% | 601 |
|
|
2018
Q1 | $8.64M | Buy |
106,535
+5,562
| +6% | +$451K | 0.02% | 856 |
|
|
2017
Q4 | $9M | Buy |
100,973
+18,473
| +22% | +$1.65M | 0.02% | 814 |
|
|
2017
Q3 | $7.68M | Sell |
82,500
-6,760
| -8% | -$629K | 0.02% | 876 |
|
|
2017
Q2 | $8.11M | Buy |
89,260
+16,762
| +23% | +$1.52M | 0.02% | 808 |
|
|
2017
Q1 | $6.36M | Buy |
72,498
+4,138
| +6% | +$363K | 0.01% | 909 |
|
|
2016
Q4 | $5.66M | Sell |
68,360
-12,300
| -15% | -$1.02M | 0.01% | 927 |
|
|
2016
Q3 | $7.46M | Buy |
80,660
+18,674
| +30% | +$1.73M | 0.02% | 743 |
|
|
2016
Q2 | $4.82M | Buy |
61,986
+14,583
| +31% | +$1.13M | 0.02% | 872 |
|
|
2016
Q1 | $3.91M | Buy |
47,403
+11,044
| +30% | +$911K | 0.01% | 944 |
|
|
2015
Q4 | $3.81M | Buy |
36,359
+6,485
| +22% | +$679K | 0.01% | 936 |
|
|
2015
Q3 | $3.15M | Sell |
29,874
-5,111
| -15% | -$538K | 0.01% | 982 |
|
|
2015
Q2 | $4.79M | Buy |
34,985
+4,562
| +15% | +$624K | 0.02% | 836 |
|
|
2015
Q1 | $3.79M | Buy |
30,423
+2,169
| +8% | +$270K | 0.02% | 876 |
|
|
2014
Q4 | $2.55M | Buy |
28,254
+4,044
| +17% | +$366K | 0.01% | 1019 |
|
|
2014
Q3 | $1.75M | Buy |
24,210
+2,893
| +14% | +$209K | 0.01% | 1164 |
|
|
2014
Q2 | $1.33M | Sell |
21,317
-6,039
| -22% | -$376K | 0.01% | 1322 |
|
|
2014
Q1 | $1.87M | Sell |
27,356
-4,020
| -13% | -$274K | 0.01% | 1076 |
|
|
2013
Q4 | $2.21M | Buy |
31,376
+13,040
| +71% | +$917K | 0.02% | 903 |
|
|
2013
Q3 | $1.32M | Buy |
18,336
+4,920
| +37% | +$355K | 0.01% | 1095 |
|
|
2013
Q2 | $748K | Buy |
+13,416
| New | +$748K | 0.01% | 1308 |
|